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To examine possible determinants of autoantibody levels at type 1 diabetes mellitus (T1DM) onset.
We assessed levels of glutamic acid decarboxylase 65 islet cell antigen (GADA) and anti-insulin
antibodies (IAA) in 247 incident T1DM cases presenting o15 years of age in Melbourne from 1st March
2008 to 30th June 2010.
58.9% (142/241) of cases were GADA seropositive and 42.3% (94/222) were IAA seropositive. Factors
associated with elevated IAA antibodies included younger age and red hair phenotype. Factors
associated with elevated GAD antibodies included lower birthweight and recent eczema. Intriguingly,
low recent or past sun exposure was only associated with elevated GADA levels among children
presenting at age o5 years, not older (difference in effect, po0.05 for 4 of 5 associations).
These ﬁndings show that environmental and phenotypic factors are associated with autoantibody
levels at time of presentation for T1DM. We recommend such environmental and phenoytypic factors
should be examined in further detail.
Crown Copyright & 2012 Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Type 1 diabetes mellitus (T1DM) is increasing among children
worldwide [1]. In Australia, the incidence has increased by 3%
annually between 2000 and 2006 [2]. In Victoria, Australia and
many locations, the incidence increase is greater among children
under 5 [3,4]. These children often have a more severe clinical
presentation, are less likely to have a honeymoon period in their
subsequent course and are more likely to be destined to have
complications by adulthood because of a prolonged disease
duration [5].
The majority of early onset T1DM have evidence of diabetes
associated autoantibodies (AA) at ﬁrst presentation, reﬂecting
pancreatic beta-cell destruction, accompanied by an autoimmune
inﬂammatory response within the pancreatic islets (‘insulitis’).
Diabetes autoimmunity occurs when autoantibodies to islet
antigens (such as antibodies against insulin or glutamic acid
decarboxylase 65), are produced before the onset of clinicalsevier B.V.
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Open access under CC BY-Ndisease [6]. The risk of progression to clinical diabetes increases
with the number of autoantibodies detected [7]. Two important
antibodies are those against the glutamic acid decarboxylase 65
islet cell antigen (GADA) and those directed against insulin (IAA).
The formation of insulin antibodies is an early event in diabetes
autoimmunity. Several large and well designed cohort studies are
now underway to assess the determinants of diabetes autoimmu-
nity and T1DM. Observational cohorts of high risk individuals
have now demonstrated that transient diabetes autoimmunity
occurs more commonly than persistent diabetes autoimmu-
nity [8]. A 2011 report comparing two similar birth cohorts from
1989 and 2000 found a similar level of diabetes autoimmunity in
both cohorts but higher clinical T1D incidence in the 2000 cohort,
concluded that ‘‘accelerated progression from islet autoimmunity
to diabetes is causing the escalating incidence of type 1 diabetes
in young children’’ [9].
An assessment of AA levels at T1DM onset can provide insights
into the possible determinants and inﬂuences on AA generation
among children who are destined to develop T1DM. It has been
known for more than thirty years that HLA-linked genetic control
inﬂuences IAA immunity [10]. Studies have reported that IAA are
associated with class I HLA-B and HLA-C types [10], and GADA
levels have been positively associated with select class II HLAC-ND license.
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AA levels vary among incident T1DM cases by age, sex and body
mass index (BMI) or disease characteristics such as diabetic
ketoacidosis [5,12,13].
However, relatively few studies have reported on the associa-
tion between past and current environmental factors or child
phenotype and the proﬁle of AA levels among T1DM children at
disease onset. In Australia, child onset T1DM incidence from 1999
to 2004 was characterised by an overrepresentation of winter
diagnoses and an inverse trend with ambient ultraviolet radiation
(UVR) levels for low population density regions, where ambient
UVR was postulated to better reﬂect child personal UVR dose [14].
We, and others, have reported fair skin pigmentation to be
overrepresented among T1DM cases [9,15,16]. Other factors such
as recent infection, diet and family history are also of interest.
Here, we aim to investigate the factors independently asso-
ciated with higher IAA and GADA levels at T1DM onset among a
clearly deﬁned sample of children residing in the Melbourne area
who presented with T1DM during 2008 to 2010 with a special
focus on children presenting with T1DM at age o5 years.2. Materials and methods
2.1. Subjects
This report is based on incident T1DM cases recruited between
March 2008 and June 2010 at the Diabetes Services, Royal
Children’s Hospital, Melbourne, Australia and the Paediatric
Diabetes Services, Monash Children’s, Monash Medical Centre,
Melbourne (Latitude 381S), Australia. These are the two tertiary
referral centres for children who develop T1DM and reside in the
Melbourne Metropolitan area. Case ascertainment has been
ascertained by capture – recapture methods to be 98% [3].
Children and their families were either interviewed during the
ﬁrst inpatient admission or at the following outpatient clinics
thereafter. Inclusion criteria were incident cases of T1DM pre-
senting at these two clinical centres age 1–14 years inclusive.
Exclusion criteria were if an infant presented with diabetes under
the age of one year, severe congenital abnormality or disease,
particularly those leading to a lack of usual school attendance.
The study interview was conducted by trained interviewers and
involved a parental questionnaire and clinical examination of the
child. Parents were asked about the amount of time their child
would normally have spent in the sun during weekends and
holidays in winter and summer at various ages using questions
with demonstrated validity [17]. Child time in the sun has been
previously associated with late winter serum 25 hydroxyvitamin
D (25OHD) levels: winter weekends (r¼0.23), winter weekdays
(r¼0.17) and winter school holidays (r¼0.22) [18]. Winter week-
end sun-exposure (o2 h, 2–3 h, 3–4 h, 44 h) in healthy girls in
an adjacent Australian state also correlated with lumbar spine
density (r¼0.29, p¼0.002) [19]. A comprehensive infection,
demographic, lifestyle and child environment history was also
recorded [15].
Written consent was obtained from parents and also from
children 12 years of age and older. Ethical approval was obtained
from the Human Research Ethics Committee of the Royal Children’s
Hospital, Melbourne, Australia and the Human Research Ethics
Committee of Monash Medical Centre, Melbourne, Australia.
2.2. Examination data
The research nurse noted the natural skin and eye colour (with
reference to standardized colour photographs) and ethnicity
(White [listed as ‘‘Caucasian’’ on the examination form], Asian,African, Australian Aboriginal or Torres Strait Islander or Middle
Eastern), and undertook a naevi count on the left arm [15,20].
Skin reﬂectance on the buttock (a non-sun exposed site), left back
shoulder, upper inner arm and hand were measured at wave-
lengths 400 and 420 nm using a hand-held spectrophotometer
(Minolta 2500d) to estimate cutaneous melanin density [21].
Previously, these spectrophotometric measurements have been
shown to be correlated (r¼0.68) with the histological measure-
ments of cutaneous melanin [21]. Other past sun markers such as
silicone rubber impressions of the dorsum of both hands [22] and
ultraviolet ﬂuorescence photography [23] were also collected but
are part of an ongoing study and have thus not yet been analysed.
2.3. Laboratory data
Overall, for the 328 eligible children who presented with
T1DM from 1st March 2008 to 30th June 2010, IAA and GADA
AA levels were determined at the time of admission. GADA was
measured by precipitation of in vitro transcribed-translated
GAD65 biosynthetically labelled with [35S]methionine. Sensitivity
and speciﬁcity in the Diabetes Autoantibody Standardisation
Programme [24] was 94% and 76%, respectively. IAA was mea-
sured by precipitation of 125I-(A14) human insulin [25]. Sensitiv-
ity and speciﬁcity of the IAA assay in the Diabetes Autoantibody
Standardisation Program was 22% and 99%, respectively. The
thresholds for GADA and IAA positivity, 5 and 1.0 units/mL,
respectively, were established as the 97.5 percentiles of unse-
lected healthy children and young adults [26]. IAA and GADA
levels were determined at the Royal Melbourne Hospital labora-
tory, Melbourne, Australia. The laboratory is a Nationally Accre-
dited Testing laboratory for these tests. AA to GADA was available
for 97.6% (241/247) of participants and IAA was available for
89.9% (222/247) of participants. The mean time between date of
ﬁrst presentation to hospital and the date of environmental
examination was 6.4 (SD 6.8) weeks.
2.4. Statistical methods
The distribution of each AA level was ﬁrst examined. The
distributions were strongly skewed and thus a logarithmic trans-
formation was used before further analysis. As there were a
number of AA levels of zero, half the next lowest value was
added to the zero’s to enable all the results to be logged. Cut-off
points for BMI for overweight and obese classiﬁcation by age and
sex were adopted from UK based criteria for children [27]. BMI
scores under the overweight cut-off point were considered
normal. Data were obtained for the monthly average of daily
total UVR dose in Standard Erythemal Doses for Melbourne from
1993 to 2010 [28]. The UVR at month of birth was the average of
UVR for the month for the years 1993–2008. This was the range of
birth years for the cases. The UVR for the month of diagnosis was
the monthly UVR assessed at the month and year of diagnosis.
UVR was similarly determined for the child’s 12th week of
gestation only for Victorian born infants. The total UVR at 12
weeks pregnancy was obtained by multiplying the number of
hours spent in the sun by the hourly UVR dose. Because the
biological effect of sun exposure depends not only on time in sun
but also the amount of skin exposed and whether exposed skin
has a sunscreen barrier, we derived a composite sun exposure
index, based partly on the total sun exposure score of Hanwell
et al., which has been shown to account for 38% of variance
(p¼0.002) in serum 25OHD for adults at a latitude of 401N [29]. A
composite child sun exposure index last summer/winter was
created. Children with greater time in the sun, less clothing, and
where data available, less sunscreen were given a higher score
(Supplementary Tables).
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related to continuous AA levels. We were also interested to
examine the presence of any AA and how factors may, in
particular, predict multiple AA. To examine factors associated
with seropositivity to both IAA and GADA, adjusted odds ratios
and 95% conﬁdence intervals were estimated by logistic regres-
sion. For multivariable analyses using either of these models,
potential confounders such age and sex were included in the
models as covariates to provide adjusted estimates of mean
difference or risk, respectively. We used Stata 11.1 software
(StataCorp, College Station, TX) for all analyses.3. Results
The case sample consisted of 247 children under 15 years of
age who were diagnosed at the two Melbourne hospitals from
1 March 2008 to 30 June 2010. The overall case participation rate
was 75.3% (247/328). The case sample was gender balanced with
47.4% (117/247) females and a mean age at diagnosis of 8.3
(SD 3.7) years. Almost all the participants were Caucasian, 90.2%
(222/246), and the skin pigmentation of the buttock was 2.5%
melanin (SD 1.5). Nearly one ﬁfth (19.0% (47/247)) of the cases
presented by age o5 years (Fig. 1). GADA seropositivity was
evident in 58.9% (142/241) of participants and IAA in 42.3%
(94/222) of participants. The majority of those seropositive for
IAA (Z1.0 units/mL) also had evidence of GADA seropositivity
(Z5 units/mL): 62.4% (58/93). Overall, 48.9% (108/221) were
seropositive to one antibody and 26.2% (58/221) were positive
to two antibodies. Among those with multiple antibodies the
quantitative titre of antibodies was only weakly correlated
(r¼0.13 (0.001 to 0.26), p-value¼0.05).
3.1. Factors associated with either IAA or GADA antibody levels.
In general, parental characteristics were not associated with
GADA levels at presentation (Table 1). The following factors were
not associated with either GADA or IAA antibody levels – maternal
exposure to cats or dogs or maternal farm residence in pregnancy.
Table 1 reports associations between child characteristics and
GADA or IAA antibodies. Older age was associated only with lower
IAA levels, with a halving of the IAA level for every four year
increase in age. IAA antibodies were positively associated with
darker skin pigmentation (Fig. 2). The geometric means (95% CI) of0
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Fig. 1. Age of onset distribution of type 1 diabetes mellitus cases presenting
during 2008–2010 in Melbourne, Australia.GAD antibodies by skin type were:-fair skin, 5.05 (2.41, 10.59);
medium/fair skin, 5.67 (3.68, 8.73); olive/medium skin, 3.54 (1.75,
7.18); olive skin, 10.93 (4.09, 29.20) and dark skin, 13.81 (2.21,
86.18). Although mean GAD antibody levels were highest for the
two categories of darker skin, an overall trend by skin type
category was not evident (p¼0.44). In contrast, the geometric
means (95% CI) of IAA antibodies by skin type were as follows: fair
skin, 0.88 (0.50, 1.53); medium/fair skin, 0.68 (0.51, 0.91); olive/
medium skin, 0.94 (0.65, 1.35); olive skin, 1.53 (0.64, 3.67) and
dark skin, 3.93 (0.01, 10.99). After adjustment for child age and sex,
the increase in IAA level by darker skin type category remained
signiﬁcant (p¼0.048). After adjustment for child age and sex, a
family history of diabetes (insulin dependent diabetes mellitus,
non insulin dependent diabetes mellitus or diabetes/gestational
diabetes) and darker skin pigmentation were positively associated
with IAA levels and these factors were taken into account in
subsequent analyses. Maternal smoking in pregnancy and current
paternal smoking were not associated with GADA or IAA levels.
Children who were reported to have had a cold or ﬂu-like
illness or a urinary tract infection in the three months prior to
diagnosis had higher IAA antibody levels than children who had
not. AA levels were not associated with asthma or hay fever
history but children reported to have had eczema over the past 12
months had ﬁve-fold higher GADA levels (Table 1). There was no
association between total, older or younger sibling number, or
body mass index or child weight with AA levels. Here, maternal
vitamin D supplementation and ﬁsh consumption tended to be
associated with slightly higher, not lower GADA levels but it must
be remembered that in Australia UVR is the major determinant of
vitamin D status [30]. Only one child consumed ﬁsh oil supple-
ments so these could not be formally examined.
3.2. Logistic regression to identify factors associated with multiple
autoantibodies
We examined how child characteristics predicted the likelihood
of having both antibodies detected vs. either no antibodies or just
one antibody (Table 2). The likelihood of seropositivity to both AA
declined with age (p¼0.02). Again, skin pigmentation appeared
important with each 1% increase in melanin density associated
with an odds ratio of 1.39 or 1.43 for multiple AA seropositivity vs.
no antibodies or one AA, respectively. Older or younger sibling
number, past sun exposure, ﬁsh consumption, recent (within the
previous 3 months) infection history and a history of asthma, hay
fever or eczema over the past year were not associated with
multiple AA seropositivity. Children with a past history of any
ear infection were more likely to exhibit multiple AA seropositivity
and a history of chicken pox was associated with a reduced
likelihood of multiple vs. no AA seropositivity.
3.3. Age at onset
We further examined if case characteristics differed by age of
onset. Unsurprisingly, younger children were less likely to report
a range of infections and to have younger mothers and fathers at
age of diagnosis. Cases presenting at age o5 years had higher IAA
levels but not GADA levels than cases presenting at an older age
(IAA geometric mean for young diagnosed 2.89 (95% CI 1.69 to
4.95), for older diagnosed 0.64 (95% CI 0.52 to 0.80), po0.001;
GADA geometric mean for young diagnosed 3.02 (95% CI 1.37 to
6.64), for older diagnosed 6.16 (95% CI 4.46 to 8.51), p¼0.07).
Individual adjustment for red hair, skin colour, buttock melanin
density, obesity, urinary tract infection in the past 3 months and a
history of lice in the past 3 months did not alter the evidence for
excess IAA levels among the younger group.
Table 1
Associations between parent and child characteristics and (log-scale) GADA and IAA levels at presentation.
GADA levels
(n¼241)
IAA levels
(n¼222)
Geometric
mean ratiosa
95% CI p
value
Geometric
mean ratiosa
95% CI p value
Parental age at diagnosis
Maternal age at diagnosis (per year) 0.99 0.92, 1.06 0.68 1.01 0.96, 1.05 0.77
Paternal age at diagnosis (per year) 0.98 0.92, 1.04 0.50 1.02 0.98, 1.06 0.32
Antenatal smoke exposure
Mother smoked during pregnancy (per increase in categoriesb) 0.70 0.44, 1.14 0.16 0.93 0.68, 1.27 0.64
Mother ever smoked during pregnancy 0.42 0.16, 1.09 0.08 0.75 0.40, 1.42 0.38
Father smoked during pregnancy (per increase in categoriesb) 1.00 0.76, 1.31 0.99 0.94 0.78, 1.14 0.54
Father ever smoked during pregnancy 0.62 0.30, 1.31 0.22 0.84 0.51, 1.39 0.51
Maternal sun exposure
Total ambient UVR levels at 12 w pregnancy during weekdays (Standard
erythemal doses per one unit increase)
0.94 0.76, 1.14 0.52 1.10 0.97, 1.24 0.15
Total ambient UVR levels at 12 w pregnancy during weekends (standard
erythemal doses per one unit increase)
0.95 0.79, 1.14 0.56 1.11 0.99, 1.24 0.07
History
Mother took vitamin D supplements during pregnancy 6.08 0.92, 40.06 0.06 2.66 0.79, 9.05 0.12
Family history of diabetes (yes vs. no) 1.76 0.94, 3.28 0.08 1.06 0.70, 1.61 0.78
Child examinationc
Hair colour (red vs. other) 2.32 0.59, 9.08 0.23 2.77 1.13, 6.80 0.03
Eye colour (blue/green vs. other) 0.87 0.47, 1.63 0.67 0.81 0.53, 1.24 0.33
Buttock melanin density (per 1% increase in melanin density) 1.09 0.89, 1.35 0.41 1.19 1.03, 1.36 0.02
BMI categoriesa
Normal weight Ref. – – Ref. – –
Overweight 1.04 0.49, 2.22 0.92 1.13 0.68, 1.89 0.64
Obese 2.40 0.59, 9.87 0.23 1.15 0.42, 3.18 0.79
Child history
Age 1.06 0.97, 1.15 0.19 0.84 0.80, 0.90 o0.001
Male 1.01 0.54, 1.90 0.96 1.03 0.68, 1.57 0.90
Birthweight (per kg) 0.51 0.30, 0.86 0.01 1.02 0.72, 1.46 0.89
Gestation (per week) 0.87 0.74, 1.03 0.10 0.98 0.88, 1.09 0.69
Sun exposure
Composite time in sun during last summer weekends (low to high sun
exposure)
0.94 0.82, 1.07 0.34 0.97 0.88, 1.06 0.47
Composite time in sun during last winter weekends (low to high sun exposure) 1.05 0.89, 1.23 0.59 0.97 0.87, 1.08 0.56
Composite time in sun during last summer holidays (low to high sun exposure) 0.91 0.80, 1.04 0.18 0.94 0.86, 1.02 0.14
Composite time in sun during last winter holidays (low to high sun exposure) 1.03 0.88, 1.19 0.73 0.92 0.84, 1.02 0.11
Fish consumption
Oily ﬁsh consumption, categoriesd 2.33 1.17, 4.64 0.02 0.76 0.47, 1.21 0.25
Oily ﬁsh eaten at least once a week 2.48 1.14, 5.38 0.02 0.75 0.43, 1.28 0.29
Infections and atopy
Inﬂuenza or cold in the past 3 months 0.96 0.50, 1.82 0.89 1.52 1.00, 2.34 0.05
Ear infection in the past 3 months 1.87 0.50, 7.03 0.36 1.90 0.75, 4.83 0.18
Urinary infection in the past 3 months 0.26 0.00, 27.64 0.57 32.46 1.65, 634.76 0.02
Lice in the past 3 months 0.82 0.30, 2.24 0.70 0.54 0.28, 1.04 0.07
Asthma in the past 12 months 0.62 0.20, 1.99 0.43 0.93 0.45, 1.94 0.84
Asthma in the past 12 months among those with asthma ever 0.41 0.08, 1.95 0.27 1.14 0.36, 3.58 0.82
Eczema in the past 12 months 4.99 1.04, 23.94 0.046 2.37 0.81, 6.90 0.12
Hay fever in the past 12 months 1.32 0.39, 4.44 0.66 1.16 0.53, 2.56 0.71
a Adjusted for age at diagnosis, sex, buttock melanin density and family history of diabetes.
b Increasing categories; nil, less than daily, 1–10 cigarettes per day, 11–20 cigarettes per day, 21–40 cigarettes per day.
c Adjusted for age at diagnosis, sex and family history of diabetes only in the child examination section.
d Increasing categories; never or occasionally, once or twice per week, three or more times a week.
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T1DM cases who were reported to spend less than one hour
outside during the last winter non-school days also had higher
(p¼0.02) GAD antibody titres (adjusted mean difference 3.64 fold
(95% CI 1.23, 10.75)) international units than cases who spent
more time outside. Table 3 examines the association between sun
exposure and GAD antibody levels by age of diagnosis. Among
T1D cases presenting at age o5 years, there is a consistent
pattern that those with higher sun exposure over the past
summer or winter weekends or holidays had lower GADA levels
after adjusting for age, sex and skin pigmentation. However,
among children diagnosed from age 5 and older, a consistent
pattern was not seen. Consistent with the above, the report ofhaving spent less than an hour in the sun in summer or winter
weekends or holidays at ages 0–2 years was associated with
increased GADA levels only for children presenting at age o5
years. The difference in the apparent effect of past sun exposure
on GADA levels by age of T1D onset was signiﬁcant (po0.05) for
4 of the 5 associations examined (Table 3).4. Discussion
A high prevalence of GAD antibody positivity and, to a lesser
extent IAA positivity was evident among T1DM cases at initial
presentation. IAA positivity was associated with younger age.
GADA levels were associated with a reduction of UVR levels in the
A.-L. Ponsonby et al. / Results in Immunology 2 (2012) 125–131 129winter prior to presentation, particularly for children presenting
at age o5 years.
Because of the marked increase in T1DM incidence among
children at age o5 years in our location [3], this report has a0
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Fig. 2. Increased skin melanin density is associated with higher IAA. Age and sex
adjusted test for trend; p-value¼0.01. R square for full model; 14.5%.
Table 2
Odds ratios for the development of both GADA and IAA vs. no autoantibodies or one a
Both AA detected (GADA and IAA) vs.
OR 95% CI
Child examinationb
Hair colour (red vs. other) 4.64 0.46, 46.74
Eye colour (blue/green vs. other) 0.83 0.37, 1.87
Buttock melanin density (per 1% increase
in melanin density)
1.39 1.04, 1.88
History
Age at diagnosis 0.87 0.77, 0.98
Male 0.94 0.41, 2.15
Family history of diabetes 1.68 0.74, 3.81
Older siblings (0, 1, 2, 3 or more) 1.20 0.76, 1.91
Younger siblings (0, 1, 2, 3 or more) 0.62 0.33, 1.17
Inﬂuenza or cold in the past 3 months 1.25 0.52, 2.98
Ear infection ever 3.28 1.32, 8.13
Chicken pox ever 0.38 0.14, 1.02
a Adjusted for age at diagnosis, sex, buttock melanin density and family history of
b Adjusted for age at diagnosis, sex and family history of diabetes only in the child
Table 3
The difference in sun’s effect on GADA levels by age of diagnosis.
Child under 5 years
Geometric
mean ratiosa
95% CI p v
Composite time in sun during last summer
weekends (low to high sun exposure)
0.58 0.38, 0.86 0.0
Composite time in sun during last winter
weekends (low to high sun exposure)
0.56 0.36, 0.89 0.0
Composite time in sun during last summer
holidays (low to high sun exposure)
0.75 0.52, 1.07 0.1
Composite time in sun during last winter
holidays (low to high sun exposure)
0.74 0.50, 1.11 0.1
Under 1 hour spent in sun during summer
weekends/holidays at ages 0–2
5.82 0.93, 36.53 0.0
a Adjusted for sex, buttock melanin density and family history of diabetes.substantial proportion of very young (aged o5 years) incident
T1DM cases. Here, we demonstrated that these incident cases
have higher IAA levels but were not able to explain the higher IAA
levels in terms of the recognised measured differences between
these younger presenting cases and those aged 5–14 years.
Younger cases also tended to have higher GADA levels and this
could partly be accounted for by a greater adverse apparent effect
of low past child sun exposure on GADA levels among children at
age o5 years at presentation.
Previously, fair skin type has been reported to be more
common among children with T1DM compared to controls [31]
and siblings [15]. Here, IAA levels at T1DM onset were higher for
children of darker pigmentation and was also higher among
children with red hair. This ﬁnding in relation to phenotype
may reﬂect underlying genotype in that HLA genotypes vary by
race and have previously been associated with antibody levels at
T1DM onset [11,32]. It may also reﬂect related UVR and vitamin D
metabolism genes. We have previously shown that the associa-
tion between vitamin D receptor gene and T1D onset varies by
regional UVR levels [33]. The accelerator hypothesis postulates
that the more obese child should develop T1DM at a younger age
and that higher insulin levels linked to insulin resistance may
underlie the formation of insulin AA [34]. Further, b cell upregu-
lation in response to obesity-linked insulin resistance may lead to
upregulated cellular enzymes and associated antibodies such asntibody.
nonea Both AA detected (GADA and IAA) vs. onea
p value OR 95% CI p value
0.19 1.34 0.35, 5.06 0.67
0.65 0.55 0.27, 1.12 0.10
0.03 1.43 1.12, 1.83 0.004
0.02 0.92 0.84, 1.01 0.08
0.87 0.73 0.35, 1.51 0.40
0.22 1.35 0.66, 2.76 0.41
0.44 1.40 0.95, 2.06 0.09
0.14 0.66 0.39, 1.14 0.14
0.62 1.03 0.50, 2.11 0.94
0.01 2.44 1.15, 5.18 0.02
0.06 0.77 0.34, 1.74 0.53
diabetes.
examination section.
Child 5–14 years p value for
difference in
effect by age
alue Geometric
mean ratiosa
95% CI p value
1 0.99 0.86, 1.14 0.92 0.01
2 1.17 0.99, 1.38 0.07 0.002
2 0.93 0.81, 1.08 0.35 0.28
5 1.11 0.95, 1.31 0.20 0.04
7 0.89 0.44, 1.81 0.75 0.04
A.-L. Ponsonby et al. / Results in Immunology 2 (2012) 125–131130GADA [34]. However, here, children under 5 were not heavier
than older T1DM children. Also, no link between obesity and
autoantibody levels at T1DM diagnosis were observed.
One prospective cohort study has demonstrated that mothers
who do not take vitamin D supplementation in pregnancy or have
lower vitamin D stores in pregnancy have offspring who are more
likely to develop AA by age 3 years [35]. However, no associations
were observed in the Finnish Diabetes Prediction and Prevention
study [36]. In Australia, vitamin D stores are predominantly
derived from radiation exposure to the skin. Here, lower sun
exposure in the winter prior to presentation was associated with
elevated GAD antibodies at onset.
Intriguingly, the association between low early life sun expo-
sure and elevated GADA antibodies was more evident among
children present with T1DM onset at age o5 years, indicating
that low early life UVR exposure or low vitamin D stores may play
a particular role in the generation of GAD antibodies among
children who develop T1DM by age 5 compared to those who
present with T1DM at older ages. However, as this is the ﬁrst
report of such an association, replication of these ﬁndings are
required. The ﬁnding of effect modiﬁcation by age of onset,
together with the ﬁndings in the Swedish cohort that maternal
vitamin D supplements were associated with GADA at 1 year but
not at 2.5 years [35] indicate that further analysis of the Finnish
cohort [36] is warranted to examine whether the null ﬁndings
overall mask a difference in the effect of maternal vitamin D
status by age of advanced autoimmunity or T1DM onset.
Strengths of this study includes that it is on a well deﬁned
population within a speciﬁc geographical area. Further this study
examined not only phenotype factors but also environmental
factors taking into account potential confounding effects of age,
sex and family history of diabetes. Limitations of this study
include that it is based on cases only, limiting causal inference
and data on HLA type, a well- known associate of autoantibody
levels, was not available. However, collection of control data is
shortly due for completion. Here, maternal vitamin D supplemen-
tation and ﬁsh consumption tended to be associated with slightly
higher, not lower GADA levels but it must be remembered that in
Australia UVR is the major determinant of vitamin D status.
Some intriguing patterns were evident in relation to early life
sun exposure. Among young cases (o5 years of age) lower
reported recent (over the past year) or past (at ages 0–2 years)
sun exposure was associated with higher GADA levels, a pattern
that generally differed signiﬁcantly to the associations evident for
T1D cases present at or above ﬁve years of age.
It has been proposed for T1DM that early life microbial
exposure may have both an adverse and also beneﬁcial effect
[37,38]. Here, a history of an upper respiratory tract infection,
inﬂuenza or urinary tract infection was associated with higher
IAA levels, consistent with a possible short term immunity
boosting effect of infection, through bystander activation or
other mechanisms [39]. A longer term inﬂuence of factors is
suggested by the ﬁnding that children with a history of any ear
infection were more likely to have multiple antibodies. Further
work is needed to determine whether this marker was evident
by chance or reﬂects an impaired host response to infection
rather than ear infection also [40].
In conclusion this study suggests environmental factors such
as sun exposure may have an inﬂuence on the development of
antibodies in childhood T1DM particularly during the early years
of life. This is a critical developmental phase for adaptive
immunity. These ﬁndings show the potential importance of
environmental and phenotypic, as well as genetic, associations
with autoantibody levels at time of presentation for T1DM
presenting under the age of 15 years. As some of our ﬁndings
were novel, they require replication in future studies of T1DM.Acknowledgements
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